W hen Whipple initially described 2-stage pancreaticoduodenectomy in this journal in 1935, 1 no portion of the stomach was removed. However, his later description in 1942 of the 1-stage pancreaticoduodenectomy 2 included a distal gastrectomy; subsequently, the resection of a portion of the stomach (with or without a truncal vagotomy) remained an integral part of pancreaticoduodenectomy during the next 4 decades. The rationale for performing a gastric resection was to prevent marginal ulceration and therefore a substantial portion of the stomach was ordinarily removed, particularly if no vagotomy was performed. In 1978, Traverso and Longmire 3 suggested that preservation of the entire stomach, pylorus, and proximal duodenum might be an acceptable alternative in cases of chronic pancreatitis and ampullary neoplasms, and reported 1 case of each. Watson 4 made a similar suggestion in 1944, but it was only after the Traverso and Longmire report that the so-called pylorus-preserving pancreaticoduodenectomy (PPPD) began to be performed regularly in some centers.
loss, transfusions, or length of operation. There was no difference in length of hospital stay. There was no difference in postoperative morbidity or mortality. Additionally, there was no increased incidence of delayed gastric emptying after PPPD, a complication which has been alleged to be more frequent after PPPD in retrospective evaluations by others. 6, 7 Most importantly, the authors found no difference in survival between the 2 operations. The manuscript is a little vague on the power of the study to detect a survival difference, but the survival curves are virtually superimposed, so it seems unlikely that a larger study would have found a biologically meaningful difference. The mean follow-up is short (18.5 months), but two-thirds of the pancreatic cancer patients have died by that time point, so it seems unlikely that longer follow-up would have made any difference in the findings.
There have been two previously reported randomized trials of PPPD versus SW, a study of 31 patients by Lin et al 8 and a study of 77 patients by Seiler et al. 9 In neither study was any survival difference demonstrated, but the studies were probably underpowered in this regard. Neither study showed any statistically significant advantage to the SW for any outcome variable.
The opposition to PPPD has been based on 2 argumentsits alleged oncologic inadequacy and the suspected higher incidence of delayed gastric emptying. A considerable experience with PPPD has shown that the incidence of positive duodenal margins is less than 5% and that survival is comparable to the SW, so there is no evidence to discredit it as a cancer operation. Delayed gastric emptying was equally common after PPPD and SW in the Netherlands randomized trial, a finding which is not particularly surprising when one considers that postoperative gastric dysmotility is thought to be related to division of the bowel and to reduction in plasma motilin concentrations. 10 The bowel is divided in both operations. If anything, motilin would be expected to be lower after the SW because of the total removal of the duodenum, the primary source of motilin.
I conclude that PPPD should become the "standard" procedure for pancreatic and peri-ampullary neoplasms. No study to date, including the well-designed one in this issue, has convincingly demonstrated any advantage to removal of the stomach and proximal duodenum, so I vote to save them. Pancreatic surgeons should move on to a new and different debate.
